WO1999062973A1 - Wax crystal modifiers formed from dialkyl phenyl fumarate - Google Patents
Wax crystal modifiers formed from dialkyl phenyl fumarate Download PDFInfo
- Publication number
- WO1999062973A1 WO1999062973A1 PCT/EP1999/003313 EP9903313W WO9962973A1 WO 1999062973 A1 WO1999062973 A1 WO 1999062973A1 EP 9903313 W EP9903313 W EP 9903313W WO 9962973 A1 WO9962973 A1 WO 9962973A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- copolymer
- group
- dialkyl phenyl
- solvent
- fumarate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G OR C10K; LIQUIFIED PETROLEUM GAS; USE OF ADDITIVES TO FUELS OR FIRES; FIRE-LIGHTERS
- C10L1/00—Liquid carbonaceous fuels
- C10L1/10—Liquid carbonaceous fuels containing additives
- C10L1/14—Organic compounds
- C10L1/18—Organic compounds containing oxygen
- C10L1/192—Macromolecular compounds
- C10L1/195—Macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- C10L1/196—Macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds derived from monomers containing a carbon-to-carbon unsaturated bond and a carboxyl group or salts, anhydrides or esters thereof homo- or copolymers of compounds having one or more unsaturated aliphatic radicals each having one carbon bond to carbon double bond, and at least one being terminated by a carboxyl radical or of salts, anhydrides or esters thereof
- C10L1/1966—Macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds derived from monomers containing a carbon-to-carbon unsaturated bond and a carboxyl group or salts, anhydrides or esters thereof homo- or copolymers of compounds having one or more unsaturated aliphatic radicals each having one carbon bond to carbon double bond, and at least one being terminated by a carboxyl radical or of salts, anhydrides or esters thereof poly-carboxylic
-
- C—CHEMISTRY; METALLURGY
- C10—PETROLEUM, GAS OR COKE INDUSTRIES; TECHNICAL GASES CONTAINING CARBON MONOXIDE; FUELS; LUBRICANTS; PEAT
- C10L—FUELS NOT OTHERWISE PROVIDED FOR; NATURAL GAS; SYNTHETIC NATURAL GAS OBTAINED BY PROCESSES NOT COVERED BY SUBCLASSES C10G OR C10K; LIQUIFIED PETROLEUM GAS; USE OF ADDITIVES TO FUELS OR FIRES; FIRE-LIGHTERS
- C10L1/00—Liquid carbonaceous fuels
- C10L1/10—Liquid carbonaceous fuels containing additives
- C10L1/14—Organic compounds
- C10L1/18—Organic compounds containing oxygen
- C10L1/192—Macromolecular compounds
- C10L1/195—Macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- C10L1/197—Macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds derived from monomers containing a carbon-to-carbon unsaturated bond and an acyloxy group of a saturated carboxylic or carbonic acid
- C10L1/1973—Macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds derived from monomers containing a carbon-to-carbon unsaturated bond and an acyloxy group of a saturated carboxylic or carbonic acid mono-carboxylic
Definitions
- the invention relates to wax crystal modifier compounds and their use in improving the flow characteristics of oleagenous fluids especially oils such as crude oil, lubricating oil, fuel oil and distillate oil.
- oils especially lubricating oils, fuel oils, distillate oils, and crude oils, contain straight chain and branched alkanes that crystallize as their temperature is lowered.
- Alkane (wax) crystallization in oleagenous fluids can affect the fluid's ability to flow. This may result in problems such as pipelininig difficulties in crudes.
- the temperature at which wax begins to crystallize in an oil is called the wax appearance temperature (WAT) of the oil.
- WAT wax appearance temperature
- Polymeric and copolymeric additive compounds can be combined with an oil in order to improve an oil's flow properties.
- Such additives known as wax crystal modifiers, are capable of altering the crystallization properties of waxes present in oil.
- wax crystal modifiers improve an oil's flow properties by suppressing the WAT or by modifying the growth of wax crystals in the oil so that the resulting crystals are small enough so as not to affect the oil's flow properties or both.
- dialkyl fumarate vinyl acetate copolymer with C to C ⁇ » alkyls is particularly popular.
- wax crystal modifiers that are capable of improving the flow properties of oleagenous fluids, especially oils such as lubricating oils, crude oils, fuel oils, and distillate oils.
- the invention is a copolymer of dialkyl phenyl fumarate and at least one compound selected from the group consisting of vinyl acetate, styrene, C 3 to C 30 ⁇ olefin, ethylene, and carbon monoxide.
- the invention is a flow improver for use in an oleagenous fluid comprising one or more copolymers from dialkyl phenyl fumarate wherein the alkyl is straight chain or branched and ranges in size from C 6 to C1 50 and at least one compound selected from the group consisting of vinyl actate, styrene, C 3 to C 30 ⁇ olefin, ethylene, and carbon monoxide.
- the invention is a method for improving the flow properties in an oleagenous fluid comprising: adding to a major amount of the oleagenous fluid a minor amount of at least one copolymer of dialkyl phenyl fumarate having C 6 to C 1 50 straight chain or branched alkyl and at least one compound selected from the group consisting of C 3 to C 3 o alpha olefin, ethylene, styrene, and carbon monoxide.
- the invention is a method for forming a copolymer comprising combining under free radical polymerization conditions a C 6 to Ciso dialkyl phenyl fumarate in a solvent selected from the group consisting of hexane, benzene, cyclohexane, and heptane; at least one compound selected from the group consisting of ethylene and carbon monoxide; and an initiator selected from the group consisting of t-butyl peroxypivalate, benzoyl peroxide, t-butylper benzoate, and t-butyl peroxide, for a time, temperature, and pressure sufficient to form the copolymer.
- the invention is a method for forming a copolymer comprising:
- copolymers can be formed having the formula AB wherein A is formed from dialkyl phenyl fumarate and B is formed from at least one compound selected from the group consisting of vinyl acetate, styrene, C 3 to C 3 o ⁇ -olefin, ethylene, and carbon monoxide.
- the invention is also based on the discovery that such copolymers are capable, when used in an effective amount, of improving flow properties like viscosity in oleagenous fluids, especially lubricating oils, fuel oils, distillate oils, and crude oils. While not wishing to be bound by any theory, it is believed that the copolymers of the invention improve the flow properties in oleagenous materials because they function as wax crystal modifiers.
- copolymers of the present invention are represented by the formula AB wherein A is formed from dialkyl phenyl fumarate (DAPhF). As such, these copolymers have the structure: B -
- Comonomer B is formed from at least one compound selected from the group consisting of vinyl acetate, styrene, C 3 to C 3 ⁇ ⁇ -olef ⁇ n, ethylene, and carbon monoxide.
- copolymer is thus used in accordance with its more general meaning where the polymer comprises two or more different monomers.
- R represents independently selected straight chain or branched alkyl groups of from about C 8 to about C ⁇ 50 carbon atoms. Preferred alkyls range from about Cg to about C 0 .
- Copolymers of the present invention are prepared from dialkyl phenyl fumarate esters.
- esters may be prepared by reacting fumaric chloride with an alkyl phenol in the presence of triethylamine.
- copolymers of this invention can be synthesized using free- radical polymerization.
- polymerizaton can be carried out in a standard glass reactor.
- inhibitors from the monomers such as vinyl acetate or styrene are removed via an inhibitor remover column.
- the purified monomers are then placed in tubes with the DAPhF ester monomers. The tubes are capped with septa and flushed with nitrogen for one to four hours before polymerization.
- the relative amounts of monomer A: monomer B in the copolymer can be varied from 5:95 to 95:5 mole percent.
- the reactions can be carried out in solvent or neat.
- solvent should be nonreactive or noninterfering in free radical polymerization can be used.
- solvents include benezene, cyclohexane, hexane, heptane, etc.
- Solvents like xylene or oil can also be used. The solvent may be flushed with argon or nitrogen and then added to the monomers.
- the polymerization reactions can be carried out from 40 to 100°C depending on reactivity of monomers, half-life of the initiator used, or the boiling point of the solvent.
- the reactions are carried out under inert atmosphere.
- the solvents are brought to the reaction temperatures, and the initiator (dissolved in the appropriate solvents) is added to the solution.
- Typical free radical initiators includes dialkyl peroxides such as ditertiary-butyl peroxide, 2,5-dimethl-2,5-di-tertiary-butylperoxyhexane, di-cumyl peroxide; alkyl peroxides such as benzoyl peroxide; peroxy esters such as tertiary-butyl peroxypivalate, tertiary-butyl perbenzoate; and also compounds such as azo-bis- isobutyronitrile.
- a free radical initiator with an appropriate half life at reaction temperature of from about 60°C to about 140°C can be used.
- both monomers and initiator are loaded together, flushed with nitrogen, and then brought to reaction temperature. T e mixture is stirred for a time sufficient to ensure that a substantially homogeneous mixture is obtained. The time and temperature if the reactions can be varied. Reactions can be stopped after 1 hour to 48 hours. The resulting copolymer can be isolated by precipitating the polymer in non-solvent (solvent in which polymer is not soluble). The product is then dried in vacuum oven.
- monomers that are gases at room temperature such as ethylene or carbon monoxide
- the reactions are generally carried out in high pressure reactors such as autoclave reactors.
- the reactor is initially charged with monomers like dialkyl phenyl fumarate dissolved in solvent like hexane, and initiator is added.
- Typical initiators include t-butyl peroxypivalate, benzoyl peroxide, t-butylper benzoate, t-butyl peroxide.
- the reactor is sealed and purged with purified nitrogen.
- the reactor is then pressurized with carbon monoxide and/or ethylene monomer to appropriate pressure.
- the pressure can range from about 100 to about 3000 psig.
- the preferred polymerization pressure ranges from about 500 to about 1200 psig.
- Reaction temperature can range from about 40 to about 200°C, depending on solvent and the initiator half-life.
- the pressure of the reaction can be maintained for few hours to 48 hours depending on monomer reactivity, solvent, and the initiator half-life.
- the reactor is allowed to cool to room temperature and is then depressurized.
- the solvent is removed on rotary evaporator to obtain the product.
- the products are generally characterized by standard techniques like FTIR, NMR, and GPC.
- wax crystal modifiers are added to the oleagenous fluid in a concentration ranging from about 10 to about 50,000 ppm based on the weight of the oleagenous fluid.
- the preferred concentration is about 500 ppm.
- oleagenous fluids containing paraffinic (alkane) species that benefit from the addition of the compounds of the invention include crude oils, i.e., oils as obtained from drilling and before refining or separating, fuel oils such as middle distillate fuel oil, and oils of lubricating viscosity ("lubricating oils").
- the oleagenous compositions and additive compounds of the present invention may be used in combination with other co-additives such as ethylene-vinyl acetate copolymers, fumarate-vinyl acetate copolymers, and mixtures thereof.
- copolymer flow improvers of this invention when present in an effective amount are capable of inhibiting the nucleation and growth of wax crystals in oleagenous fluids such as oils. While not wishing to be bound by any theory, it is believed that the presence of an effective amount of copolymer results in a lowering the oil's wax appearance temperature because the copolymer molecules are sufficiently similar to the paraffinic crude species to incorporate themselves into growing wax crystals. Once incorporated, it is believed that the polymeric nature of the flow improver, i.e., its "branchiness" and high molecular weight, prevent the further addition of the crude's paraffinic species to the crystal.
- the presence of the copolymer in the growing wax crystal is also believed to alter the crystals' morphology by inhibiting growth that naturally tends towards undesirable large flat platelets. Such platelets are believed to result from the interlocking, intergrowth, and agglomeration of nucleated wax crystallites. Such changes in crystal shape resulting from copolymer incorporation greatly diminish the wax crystals' ability to interlock, intergrow, and agglomerate.
- the compounds of the present invention are most effective when the molecular weight distribution of the alkyls present in the fumaric species of the copolymer is approximately the same as the molecular weight distribution of the oil's paraffinic species. While the compounds of the present invention are useful in all olegenous fluids containing paraffinic species, the preferred compound will depend on the type of fluid used.
- copolymers with alkyls in the fumarate species ranging from about C 12 to about C ⁇ and molecular weights ranging from about 2000 to about 100,000 are preferred.
- the preferred compounds contain alkyls ranging from about C1 5 to about C o and molecular weights ranging from about 2,000 to about 50,000.
- preferred copolymers contain alkyls ranging from about C 10 to about C 22 and have molecular weights ranging from about 2,000 to about 20,000.
- alkyl chain lengths are sometimes represented by a range of carbon and hydrogen atoms, such as C24-28H49.57. h such cases, the alkyl groups present in the fumaric species of the inventions monomers, polymers, and copolymers are random mixtures of alkyl groups ranging in size, approximately, over the entire range.
- Example 1 Reaction of fumaric chloride and dodecyl phenol.
- Example 2 The synthesis of dialkyl phenyl fumarate monomer (C ⁇ nPhF
- C 3 o+ olefm alkylated phenol was synthesized by reaction of phenol with C 3 o+ alpha olefm using a strongly acidic resin (obtained from Aldrich, Inc., Milwaukee, WI under the tradename AMBERLYST 15TM) comprising divinyl benzene-crosslinked polystyrene, to which sulfonic groups are attached, as a catalyst.
- C 30 + phenol fumarate ester was synthesized using a procedure similar to that used to synthesize dodecyl phenol fumarate.
- An IRspectrum of the product showed absorption peaks due to ester carbonyl at 1757 and 1710 cm "1 and the double bond peak at 1641 cm "1 .
- the product also showed a peak at 1606 cm due to an aromatic ring.
- the aliphatic region of the spectrum suggests that alkyl chains are substantially linear.
- C 24 - 2 8 + olefm alkylated phenol was synthesized by reaction of phenol with C 2 4- 2 8 + alpha olefm using a strongly acidic resin (obtained from Aldrich, Inc., Milwaukee, WI under the tradename AMBERLYST 15TM) comprising divinyl benzene-crosslinked polystyrene, to which sulfonic groups are attached, as a catalyst.
- C 2 4- 3 0+ phenol fumarate ester synthesized using a procedure similar to that used to synthesize dodecyl phenol fumarate.
- An IR spectrum of the product showed absorption peaks due to ester carbonyl at 1746 and 1710 cm "1 and the double bond peak at 1645 cm "1 .
- the product also showed a peak at 1605 cm '1 due to an aromatic ring.
- the aliphatic region of the spectrum suggests that alkyl chains are substantially linear.
- Example 4 The synthesis of dialkyl phenyl fumarate/carbon monoxide copolymer
- Copolymers of dialkyl phenyl fumarate with vinyl acetate were synthesized with R groups of C12H25, C24-28, H49. 5 , C 30 H i. Such copolymers have the structure
- Copolymers were formed using free-radical polymerization techniques as follows:
- Hydroquinone inhibitor was removed from the vinyl acetate by passing it through an inhibitor remover column.
- the purified vinyl acetate was placed in tubes with the dialkyl phenyl fumarate ester monomers.
- the tubes were capped with septa and flushed with nitrogen for one hour.
- the solvent was flushed with nitrogen and added to the tubes containing the monomers.
- the solutions were brought to their reaction temperatures, and the initiator (dissolved in the appropriate solvents) was added to each monomer solution.
- both monomers and initiator were loaded together, flushed with nitrogen, and then brought to reaction temperature. The mixtures were stirred overnight. The next day, the polymer solutions were precipitated in methanol and vacuum dried.
- Table 1 sets forth copolymerization reaction details.
- 3% azobisisobutyronitrile is available from Aldrich, Inc., Milwaukee, WI under the tradename ALBNTM, and 3% [l,l'-azobis(cyanocyclohexane)] is an available from DuPont Chemicals, Wilmington, DE under the tradename V-88TM.
- C ⁇ PhF Didodecylphenol fumarate
- PI1F Di[p-alkyl (C 30 ) phenyl] fumarate
- PhF Di[p-alkyl (C 24 - 2 s)phenyl] fumarate
- Dialkyl phenyl fumarate - styrene copolymer having the structure:
- R C 3 oH 6 i or C24- 28 H4 9 .57
- Copolymers were synthesized according to the polymerization conditions set forth in Examples 5 through 9.
- Tables 3 and 4 show the polymerization conditions and characterization results, respectively.
- DSC differential scanning colormetry
- WAT is a measure of the thermodynamic barrier for the formation of a stable nucleus for further crystal growth. It is the temperature at which stable wax crystals first begin to appear. For wax crystallization to take place, solutions have to be supercooled to cross this thermodynamic free energy barrier to nucleation. A lowering of the WAT is desirable, because it indicates a larger thermodynamic barrier for further wax crystal growth. Additives that interfere with the nucleation stage of wax formation increase the free energy barrier and, thereby, decrease the WAT. Larger decrease in WAT indicate better performance of the wax crystal modifier additive.
- Table 5 shows that the additives of the present invention are effective wax crystal modifiers.
Landscapes
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Lubricants (AREA)
- Polyethers (AREA)
Abstract
Description
Claims
Priority Applications (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU42616/99A AU4261699A (en) | 1998-05-29 | 1999-05-13 | Wax crystal modifiers formed from dialkyl phenyl fumarate |
| JP2000552180A JP2002517531A (en) | 1998-05-29 | 1999-05-13 | Wax crystal modifier formed from dialkylphenyl fumarate |
| EP99955277A EP1091987A1 (en) | 1998-05-29 | 1999-05-13 | Wax crystal modifiers formed from dialkyl phenyl fumarate |
| CA002333571A CA2333571A1 (en) | 1998-05-29 | 1999-05-13 | Wax crystal modifiers formed from dialkyl phenyl fumarate |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8725698A | 1998-05-29 | 1998-05-29 | |
| US09/087,256 | 1998-05-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO1999062973A1 true WO1999062973A1 (en) | 1999-12-09 |
Family
ID=22204069
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/EP1999/003313 Ceased WO1999062973A1 (en) | 1998-05-29 | 1999-05-13 | Wax crystal modifiers formed from dialkyl phenyl fumarate |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1091987A1 (en) |
| JP (1) | JP2002517531A (en) |
| AU (1) | AU4261699A (en) |
| CA (1) | CA2333571A1 (en) |
| WO (1) | WO1999062973A1 (en) |
Cited By (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1717296A1 (en) | 2005-04-30 | 2006-11-02 | Clariant Produkte (Deutschland) GmbH | Additives for low sulfur mineral oil distillates, comprising aromatics carrying a hydroxyl group, a methoxy group and an acid function. |
| US8148414B2 (en) | 2008-08-19 | 2012-04-03 | Xenoport, Inc. | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| WO2015094942A1 (en) | 2013-12-19 | 2015-06-25 | The Lubrizol Corporation | Hydrogenated natural oils in rust preventive coatings |
| US9302977B2 (en) | 2013-06-07 | 2016-04-05 | Xenoport, Inc. | Method of making monomethyl fumarate |
| US9416096B2 (en) | 2013-09-06 | 2016-08-16 | Xenoport, Inc. | Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use |
| US9421182B2 (en) | 2013-06-21 | 2016-08-23 | Xenoport, Inc. | Cocrystals of dimethyl fumarate |
| US9505776B2 (en) | 2013-03-14 | 2016-11-29 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US9597292B2 (en) | 2012-08-22 | 2017-03-21 | Xenoport, Inc. | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
| US9604922B2 (en) | 2014-02-24 | 2017-03-28 | Alkermes Pharma Ireland Limited | Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases |
| US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
| US10179118B2 (en) | 2013-03-24 | 2019-01-15 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
| US10945984B2 (en) | 2012-08-22 | 2021-03-16 | Arbor Pharmaceuticals, Llc | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468453A (en) * | 1982-07-06 | 1984-08-28 | Asahi Kasei Kogyo Kabushiki Kaisha | Dry process for forming an image |
| US4670130A (en) * | 1984-03-14 | 1987-06-02 | Exxon Research & Engineering Co. | The use of dialkyl fumarate-vinyl acetate copolymers as dewaxing aids |
| EP0385728A2 (en) * | 1989-02-28 | 1990-09-05 | Exxon Chemical Patents Inc. | C14 carboxylate polymer and viscosity index improver containing oleaginous compositions |
-
1999
- 1999-05-13 EP EP99955277A patent/EP1091987A1/en not_active Withdrawn
- 1999-05-13 AU AU42616/99A patent/AU4261699A/en not_active Abandoned
- 1999-05-13 CA CA002333571A patent/CA2333571A1/en not_active Abandoned
- 1999-05-13 WO PCT/EP1999/003313 patent/WO1999062973A1/en not_active Ceased
- 1999-05-13 JP JP2000552180A patent/JP2002517531A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468453A (en) * | 1982-07-06 | 1984-08-28 | Asahi Kasei Kogyo Kabushiki Kaisha | Dry process for forming an image |
| US4670130A (en) * | 1984-03-14 | 1987-06-02 | Exxon Research & Engineering Co. | The use of dialkyl fumarate-vinyl acetate copolymers as dewaxing aids |
| EP0385728A2 (en) * | 1989-02-28 | 1990-09-05 | Exxon Chemical Patents Inc. | C14 carboxylate polymer and viscosity index improver containing oleaginous compositions |
Cited By (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1717296A1 (en) | 2005-04-30 | 2006-11-02 | Clariant Produkte (Deutschland) GmbH | Additives for low sulfur mineral oil distillates, comprising aromatics carrying a hydroxyl group, a methoxy group and an acid function. |
| US9452972B2 (en) | 2008-08-19 | 2016-09-27 | Xenoport, Inc. | Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof |
| US8148414B2 (en) | 2008-08-19 | 2012-04-03 | Xenoport, Inc. | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| US8778991B2 (en) | 2008-08-19 | 2014-07-15 | Xenoport, Inc. | Prodrugs of methyl hydrogen fumarate, pharmaceutical compositions thereof, and methods of use |
| US8785443B2 (en) | 2008-08-19 | 2014-07-22 | Xenoport, Inc. | Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof |
| US10940117B2 (en) | 2012-08-22 | 2021-03-09 | Arbor Pharmaceuticals, Llc | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
| US10716760B2 (en) | 2012-08-22 | 2020-07-21 | Arbor Pharmaceuticals, Llc | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
| US10945984B2 (en) | 2012-08-22 | 2021-03-16 | Arbor Pharmaceuticals, Llc | Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects |
| US9597292B2 (en) | 2012-08-22 | 2017-03-21 | Xenoport, Inc. | Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof |
| US11230548B2 (en) | 2013-03-14 | 2022-01-25 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US9505776B2 (en) | 2013-03-14 | 2016-11-29 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US12076306B2 (en) | 2013-03-14 | 2024-09-03 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US11905298B2 (en) | 2013-03-14 | 2024-02-20 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US11679092B2 (en) | 2013-03-14 | 2023-06-20 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US9090558B2 (en) | 2013-03-14 | 2015-07-28 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US11083703B2 (en) | 2013-03-14 | 2021-08-10 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US10406133B2 (en) | 2013-03-14 | 2019-09-10 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US10596140B2 (en) | 2013-03-14 | 2020-03-24 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US8669281B1 (en) | 2013-03-14 | 2014-03-11 | Alkermes Pharma Ireland Limited | Prodrugs of fumarates and their use in treating various diseases |
| US11938111B2 (en) | 2013-03-24 | 2024-03-26 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
| US10179118B2 (en) | 2013-03-24 | 2019-01-15 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
| US12440468B2 (en) | 2013-03-24 | 2025-10-14 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of dimethyl fumarate |
| US9302977B2 (en) | 2013-06-07 | 2016-04-05 | Xenoport, Inc. | Method of making monomethyl fumarate |
| US9421182B2 (en) | 2013-06-21 | 2016-08-23 | Xenoport, Inc. | Cocrystals of dimethyl fumarate |
| US9682057B2 (en) | 2013-09-06 | 2017-06-20 | Xenoport, Inc. | Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use |
| US9416096B2 (en) | 2013-09-06 | 2016-08-16 | Xenoport, Inc. | Crystalline forms of (N,N-Diethylcarbamoyl)methyl methyl (2E)but-2-ene-1,4-dioate, methods of synthesis and use |
| US9920221B2 (en) | 2013-12-19 | 2018-03-20 | The Lubrizol Corporation | Hydrogenated natural oils in rust preventative coatings |
| WO2015094942A1 (en) | 2013-12-19 | 2015-06-25 | The Lubrizol Corporation | Hydrogenated natural oils in rust preventive coatings |
| US9604922B2 (en) | 2014-02-24 | 2017-03-28 | Alkermes Pharma Ireland Limited | Sulfonamide and sulfinamide prodrugs of fumarates and their use in treating various diseases |
| US9999672B2 (en) | 2014-03-24 | 2018-06-19 | Xenoport, Inc. | Pharmaceutical compositions of fumaric acid esters |
| US11135296B2 (en) | 2014-03-24 | 2021-10-05 | Arbor Pharmaceuticals, Llc | Pharmaceutical compositions of fumaric acid esters |
Also Published As
| Publication number | Publication date |
|---|---|
| AU4261699A (en) | 1999-12-20 |
| EP1091987A1 (en) | 2001-04-18 |
| CA2333571A1 (en) | 1999-12-09 |
| JP2002517531A (en) | 2002-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6444784B1 (en) | Wax crystal modifiers (LAW657) | |
| WO1999062973A1 (en) | Wax crystal modifiers formed from dialkyl phenyl fumarate | |
| US5200484A (en) | Terpolymers of ethylene, their preparation and their use as additives for mineral oil distillates | |
| US7297823B2 (en) | Additives for inhibiting the formation of gas hydrates | |
| AU2013361819A1 (en) | Polymer compositions of ethylene-vinyl ester copolymers and alkyl(meth)acrylates, method for the production thereof and use thereof as pour-point depressants for crude oils, mineral oils or mineral oil products | |
| KR102357888B1 (en) | Additives for fuels and oils comprising functionalised diblock copolymers | |
| US5721201A (en) | Polymeric flow improver additives | |
| EP0649456A1 (en) | Oil additives and compositions | |
| KR102628852B1 (en) | Use of polymer additives for paraffin-containing fluids | |
| JPH07508300A (en) | Oil additives and compositions | |
| US20150291717A1 (en) | Preparation of low-viscosity polymers | |
| US6025308A (en) | Amine-functionalized polymers | |
| KR100618755B1 (en) | Polymerization processes using dilute multi-component feeds | |
| WO1999063029A1 (en) | Dialkyl fumarate copolymers and their use as flow improvers in oleaginous fluids | |
| KR100910318B1 (en) | Polymers based on olefins and alkenyl alkylates and their use as polyfunctional additives in fuels and combustibles | |
| US5205839A (en) | Terpolymers of ethylene, their preparation and their use as additives for mineral oil distillates | |
| KR101903790B1 (en) | Improvements in polymers | |
| JP4632547B2 (en) | Improved process for producing free radical polymerized copolymers | |
| KR100487077B1 (en) | Pour Point Depressant for Diesel Oil | |
| JPH07508293A (en) | Poly(vinyl ether) amine and fuel composition containing the same | |
| KR20180095336A (en) | Compound For Cold Flow Imporover And Cold Flow Improver Using The Same | |
| JP2005194423A (en) | Fluidity improver for fuel oil | |
| JPS61287985A (en) | Method of improving low-temperature flowability of fuel oil | |
| JPH09118743A (en) | Polylactone aromatic ester and fuel composition containing it | |
| JPH08501802A (en) | Poly (alkylene ether) hydroxy (oxypropylene) amine and fuel composition containing the same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BB BG BR BY CA CH CN CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 1999955277 Country of ref document: EP |
|
| ENP | Entry into the national phase |
Ref document number: 2333571 Country of ref document: CA |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWP | Wipo information: published in national office |
Ref document number: 1999955277 Country of ref document: EP |
|
| NENP | Non-entry into the national phase |
Ref country code: CA |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1999955277 Country of ref document: EP |








